A Quarter That Forced the Market to Take Notice
There is a particular satisfaction in watching a high-conviction position do exactly what my thesis said it would, on the exact timeline the thesis implied. On 12 August, Marex Group (NASDAQ: MRX) delivered that satisfaction in spades. The diversified commodities and financial services platform reported second-quarter results so far ahead of consensus that the market did something markets rarely do to a mid-cap financial: it sent the shares up almost 19% in a single session.
The numbers earn the reaction. Second-quarter revenue rose 39% year-on-year to $695.8 million, comfortably outpacing every segment forecast on the Street. Adjusted profit before tax climbed 56% to $165.9 million, lifting the adjusted margin to 23.8% from a level that, twelve months earlier, would have been considered a good year rather than a good quarter. Adjusted diluted earnings per share came in at $1.64 against a consensus estimate of $1.36 — a 20.6% surprise, and the fourth consecutive quarter in which Marex has beaten the Street. For the first half of 2026, revenue reached $1.39 billion, up 43%, with adjusted profit before tax up 57% to $318.6 million.
Broad-Based Growth Across Marex
What makes this beat worth writing about, rather than simply filing away, is where the growth came from. This was not a single desk having a lucky quarter. Agency and execution revenue rose 35% to $351 million, and market making revenue more than doubled to over $118 million. All four business segments grew. That breadth is precisely the quality Fenestra’s GARP screen was built to reward: a business whose earnings power does not depend on one trading book, one commodity cycle, or one client relationship.
Capital, Acquisitions and the Bermuda Move
The corporate story moved just as fast as the trading story. Marex completed its domiciliation to Bermuda on 1 July, a structural shift aimed at capital efficiency and long-term flexibility. Alongside it, the group issued $500 million of hybrid capital and $500 million of senior unsecured notes — a deliberate strengthening of the balance sheet ahead of, not in response to, further growth. And growth is exactly what management is pursuing: the completed acquisitions of Bright Point, Levmet and Webb Traders were joined this month by an agreement to acquire Brainchild Capital Investments, continuing a pattern of disciplined, capability-adding bolt-ons rather than scale for its own sake. Webb Traders in particular brings European equity derivatives market-making expertise that plugs directly into the segment that just doubled its revenue.
The Sell Side Re-Rates Marex
The sell side has caught up quickly. Jefferies lifted its price target from $57 to $80 in mid-July, reiterating its Buy rating, and Piper Sandler moved from $55 to $75 around the same time — both calls made before the second-quarter print vindicated them. With the shares now trading in the low-$70s, the market has re-rated Marex meaningfully in a matter of weeks, yet has not yet closed the gap to where the most bullish analysts, or Fenestra, see fair value.
What Could Still Go Wrong?
A conscientious analyst owes the position some scrutiny before celebrating it. Roughly $35 million of the half’s pre-tax profit came from the disposal of Winterflood’s custody business — a genuine gain, but a non-recurring one, and it flatters the headline margin expansion by a few points. Insiders have been net sellers over the trailing 90 days, which is worth monitoring even if it is not, on its own, a reason to doubt the operating story. And a company integrating four acquisitions inside twelve months while simultaneously redomiciling and reshaping its capital structure is a company with more moving parts than usual — execution risk is real, even when execution has, so far, been excellent.
Why Marex Still Passes Fenestra’s GARP Screen
For Fenestra clients specifically, the read-through matters beyond the position itself. Marex sits in a portfolio built around a simple discipline — ten names, screened hard on PEG, ROIC, free cash flow yield and moat durability, with no exceptions made for a good story that fails the numbers. It is easy to hold a winner when it is winning; the harder test is whether the same discipline would buy it today, at today’s price, on today’s facts. Having re-run the screen against the second-quarter numbers, the answer is yes. The margin trajectory, the segment diversification, and the balance sheet discipline behind the Bermuda move all strengthen rather than weaken the case, even after accounting for the one-off gain and the near-term integration load.
The Investment Thesis Remains Intact
None of that changes the conclusion. Marex now serves more than 3,400 active clients across over 60 exchanges, a franchise Fenestra flagged as a durable, diversified moat well before the 12 August results confirmed it. The PEG math, the return on invested capital trajectory, and the free cash flow generation that first earned Marex its place in Fenestra’s concentrated ten-position portfolio has all moved in the right direction, not the wrong one.
Request a Portfolio Review
If you are not happy with your portfolio performance or would like a second opinion, please do not hesitate to contact Fenestra for a free review of your portfolio.
William Meyer – 0796244031
Frequently Asked Questions
Why did Marex Group’s share price jump after its second-quarter results?
The article attributes the move to results that came in materially ahead of expectations, including 39% year-on-year revenue growth, a 56% rise in adjusted profit before tax and broad-based growth across Marex’s business segments.
What drove Marex Group’s growth in the quarter?
The article highlights 35% growth in agency and execution revenue, market-making revenue that more than doubled, and growth across all four operating business segments rather than dependence on a single trading activity.
Why does Marex still meet Fenestra’s GARP criteria?
Fenestra says it has re-run its screen using the latest results and continues to see support from Marex’s margin trajectory, diversification and balance-sheet discipline, alongside its assessment of PEG, return on invested capital, free cash flow yield and moat durability.
What risks does Fenestra identify for Marex?
The article highlights insider selling and the execution risk involved in integrating multiple acquisitions while simultaneously completing a redomiciliation and reshaping the group’s capital structure.
What price targets does the article cite for Marex?
The article cites an $80 target from Jefferies, which retained a Buy rating, and a $75 target from Piper Sandler.
Has Fenestra changed its investment thesis on Marex?
No. The article states that after re-running its investment screen against the second-quarter results, Fenestra’s conclusion remains positive and Marex continues to qualify for its concentrated portfolio.
Important information: Past performance is not indicative of future performance. Investment values are not guaranteed, and investors are subject to normal market risks.


